O. S. Moore and F. W. Foote, The relatively favorable prognosis of medullary carcinoma of the breast, Cancer, vol.2, pp.635-677, 1949.

S. S. Malyuchik and R. G. Kiyamova, Medullary breast carcinoma, Exp Oncol, vol.30, pp.96-101, 2008.

I. Park, J. Kim, M. Kim, S. Y. Bae, S. K. Lee et al., Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma, J Breast Cancer, vol.16, pp.417-442, 2013.

P. G. Tsoutsou, A. D. Durham, and M. C. Vozenin, A need for biology-driven personalized radiotherapy in breast cancer, Breast Cancer Res Treat, vol.167, issue.2, pp.603-607, 2018.

M. Beguinot-cornillon, M. Dauplat, F. Kwiatkowski, G. Lebouedec, L. Tixier et al., Analysis of tumor-infiltrating lymphocytes (TILs) reveals biologically different subgroups of breast ductal carcinoma in situ, AACR Annu Meet, vol.18, issue.1, p.129, 2018.

Z. Liu, M. Li, Z. Jiang, and X. Wang, A comprehensive immunologic portrait of triple-negative, Transl Oncol, vol.11, issue.2, pp.311-340, 2018.

S. Hendry, R. Salgado, T. Gevaert, P. A. Russell, T. John et al., Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research, Adv Anat Pathol, vol.24, pp.235-51, 2017.

J. R. Mcdaniel, S. C. Pero, W. N. Voss, G. S. Shukla, Y. Sun et al., Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node, Cancer Immunol Immunother, vol.67, issue.5, pp.729-767, 2018.

M. V. Dieci, N. Radosevic-robin, S. Fineberg, G. Van-dern-eynden, N. Ternes et al., Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: a report of the International Immuno, Oncology Biomarker Working Group on Breast Cancer. Semin Cancer Biol, vol.10, pp.1-11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01675219

J. Goc, W. H. Fridman, C. Sautès-fridman, and M. C. Dieu-nosjean, Characteristics of tertiary lymphoid structures in primary cancers, Oncoimmunology, vol.2, pp.1-9, 2013.

M. C. Dieu-nosjean, J. Goc, N. A. Giraldo, C. Sautès-fridman, and W. H. Fridman, Tertiary lymphoid structures in cancer and beyond, Trends Immunol, vol.35, pp.571-80, 2014.

J. D. Shields, I. C. Kourtis, A. A. Tomei, J. M. Roberts, and M. A. Swartz, Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21, Science, vol.328, pp.749-52, 2010.

A. Johansson-percival, B. He, Z. J. Li, A. Kjellén, K. Russell et al., De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors, Nat Immunol, vol.18, pp.1207-1224, 2017.

N. S. Joshi, E. H. Akama-garren, Y. Lu, L. Dy, G. P. Chang et al., Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses, Immunity, vol.43, pp.579-90, 2016.

R. R. Weichselbaum, H. Liang, L. Deng, and Y. X. Fu, Radiotherapy and immunotherapy: a beneficial liaison, Nat Rev Clin Oncol, vol.14, pp.365-79, 2017.

M. Spiotto, Y. Fu, and R. R. Weichselbaum, The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications, Sci Immunol, vol.1, issue.3, p.1266, 2016.

B. Burnette and R. R. Weichselbaum, Radiation as an immune modulator, Semin Radiat Oncol, vol.23, pp.273-80, 2013.

R. E. Vatner and S. C. Formenti, Myeloid-derived cells in tumors: effects of radiation, Semin Radiat Oncol, vol.25, pp.18-27, 2015.

M. Dupage, A. L. Dooley, and T. Jacks, Conditional mouse lung cancer models using adenoviral or lintiviral delivery of Cre recombinase, Nat Protoc, vol.4, pp.1064-72, 2009.

J. Faget, S. Groeneveld, G. Boivin, M. Sankar, N. Zangger et al., Neutrophils and snail orchestrate the establishment of a pro-tumor microenvironment in lung cancer, Cell Rep, vol.21, pp.3190-204, 2017.

, Frontiers in Oncology | www.frontiersin.org, vol.8, p.256, 2018.

A. Huang, S. Cao, and L. Tang, The tumor microenvironment and inflammatory breast cancer, J Cancer, vol.8, pp.1884-91, 2017.

N. Hiraoka, Y. Ino, and R. Yamazaki-itoh, Tertiary lymphoid organs in cancer tissues, Front Immunol, vol.7, p.244, 2016.

D. M. Carragher, J. Rangel-moreno, and R. Td, Ectopic lymphoid tissues and local immunity, Semin Immunol, vol.20, pp.26-42, 2008.

J. Alsughayyir, G. J. Pettigrew, and R. Motallebzadeh, Spoiling for a fight: B lymphocytes as initiator and effector populations within tertiary lymphoid organs in autoimmunity and transplantation, Front Immunol, vol.8, p.1639, 2017.

F. Djenidi, J. Adam, A. Goubar, A. Durgeau, G. Meurice et al., CD8+CD103+ tumor? infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients, J Immunol, vol.194, issue.7, pp.3475-86, 2015.

M. Dupage, A. F. Cheung, C. Mazumdar, M. M. Winslow, R. Bronson et al., Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression, Cancer Cell, vol.19, pp.72-85, 2011.